Astellas Pharma (Verekitug Asthma Drug) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Astellas Pharma (Verekitug Asthma Drug) General Information

Description

An asthma drug. The asset is a novel recombinant fully human immunoglobulin monoclonal antibody that binds to the thymic stromal lymphopoietin receptor and inhibits its signaling

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Tokyo
  • Japan
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Corporate Office
  • Tokyo
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Astellas Pharma (Verekitug Asthma Drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Astellas Pharma (Verekitug Asthma Drug)‘s full profile, request access.

Request a free trial

Astellas Pharma (Verekitug Asthma Drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Astellas Pharma (Verekitug Asthma Drug)‘s full profile, request access.

Request a free trial

Astellas Pharma (Verekitug Asthma Drug) FAQs

  • Where is Astellas Pharma (Verekitug Asthma Drug) headquartered?

    Astellas Pharma (Verekitug Asthma Drug) is headquartered in Tokyo, Japan.

  • What industry is Astellas Pharma (Verekitug Asthma Drug) in?

    Astellas Pharma (Verekitug Asthma Drug)’s primary industry is Buildings and Property.

  • Is Astellas Pharma (Verekitug Asthma Drug) a private or public company?

    Astellas Pharma (Verekitug Asthma Drug) is a Private company.

  • What is Astellas Pharma (Verekitug Asthma Drug)’s current revenue?

    The current revenue for Astellas Pharma (Verekitug Asthma Drug) is .

  • Who are Astellas Pharma (Verekitug Asthma Drug)’s investors?

    Astellas Pharma has invested in Astellas Pharma (Verekitug Asthma Drug).

  • When was Astellas Pharma (Verekitug Asthma Drug) acquired?

    Astellas Pharma (Verekitug Asthma Drug) was acquired on 01-Oct-2021.

  • Who acquired Astellas Pharma (Verekitug Asthma Drug)?

    Astellas Pharma (Verekitug Asthma Drug) was acquired by Upstream Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process